Loading...
OTCM
AVVH
Market cap2mUSD
Apr 09, Last price  
0.00USD
1D
1.45%
1Q
-17.94%
IPO
-94.42%
Name

avVaa World Health Care Products Inc

Chart & Performance

D1W1MN
OTCM:AVVH chart
P/E
P/S
28.21
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
-6.94%
Revenues
96k
+412.28%
01009,40913,02118,65795,577
Net income
-4m
L+10.80%
-267,532-252,21537,589-819,608-2,230,958-3,145,775-4,035,067-4,470,747
CFO
-1m
L+2.53%
-136,923-159,225-92,875-415,892-918,838-1,194,594-1,309,104-1,342,252

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

AVVAA World Health Care Products, Inc. provides natural and therapeutic skin care products worldwide. The company is a biotechnology company which primarily focuses on manufacturing and marketing over-the-counter the Neuroskin line of products used for the treatment of skin abnormalities, and to enhance the natural clarity and texture of healthy skin through mass marketing food and drug channels. It also has distribution rights for patented European skin care products, which are scientifically developed to treat the symptoms of skin diseases, including eczema, psoriasis, and acne. The company also offers a line of natural animal care products, which is a grooming treatment for dogs, cats, horses, and other pets. AVVAA World Health Care Products, Inc. was incorporated in 1998 and is based in Richmond, Virginia. As of June 23, 2021, AVVAA World Health Care Products, Inc. operates as a subsidiary of Gold Quest Capital, Inc.
IPO date
Feb 23, 2001
Employees
5
Domiciled in
CA
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FY
2025‑05
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT